旗下30餘家公司被曝商票逾期 牧原股份(002714.SZ)低開6.03%
格隆匯12月7日丨牧原股份(002714.SZ)低開6.03%,報48.5元,暫成交2億元,最新市值2552億元。牧原股份迴應旗下公司商票逾期:公司關注到,上海票據交易所今日公示了《截至2021年11月30日持續逾期名單》,經公司核查,由於部分持票人未及時發起提示付款申請或選擇的清算方式不符合銀行要求等原因,導致公司無法按時兑付商票。針對上述問題,公司已積極與持票人、銀行溝通,推動商票兑付,保障持票人的合法權益。目前公司生產經營與現金流情況一切正常。公司已針對相關情況出台了專項管理制度與措施,未來將加強票據管理,避免類似事件發生。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.